See-Mode Technologies' AI-powered Ultrasound Software Secures Regulatory Approval in Australia and New Zealand.

"We are thrilled to receive regulatory approvals for our product in Australia and New Zealand," said Dr Milad Mohammadzadeh, Co-Founder...

 March 22, 2023 | News

FDA approves expanded indication for Telix's Illuccix® for PSMA-directed therapy

The label expansion means Illuccix is now approved in the U.S. to identify and select patients who are candidates for the only FDA-approved prostate-specif...

 March 16, 2023 | News

Telix's Revolutionary Kidney Cancer Imaging Study Takes Center Stage at EAU's 'Game Changing' Session

The results were featured in a "Game Changing" oral session delivered by Professor Dr. Peter Mulders from Radboud University Medical Centre (Neth...

 March 14, 2023 | News

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EAU

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

 March 09, 2023 | News

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

The clinical trial to be conducted by Peter Mac will be the first time a CAR-T cell therapy product containing the genetic modifications incorporated into ...

 February 27, 2023 | News

Precision Medicine Takes Center Stage: Exploring the Innovative Biopharma Industry in Australia and New Zealand

Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...

 February 24, 2023 | News

Chrysalis Advisory and TriNetX collaborate to aid research teams in Australia and New Zealand

The goal of the collaboration is to extend the availability of consulting services to healthcare organizations in the region who are in need of assistance ...

 February 22, 2023 | News

GNOMIX: Australian Study Uses MGI's DNBSEQ™ Platforms to Make Genomics Applications Accessible to All

Currently the clinical genomics landscape in Australia is strongly influenced by a couple of major players heavily driven by profit to provide a ...

 February 17, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

 February 16, 2023 | News

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.

 In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is prou...

 February 15, 2023 | News

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

 February 13, 2023 | News

AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva

AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...

 February 10, 2023 | News

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...

 February 09, 2023 | News

Microba and BioAgilytix announce partnership to fast-track therapeutic delivery

  Enables innovators to confidently leverage microbiome endpoints in clinical trials Delivers superior outcomes for clients at each stage of the d...

 February 09, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in